Books on the topic 'Cardiovascular disease diagnostic equipment industry'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 35 books for your research on the topic 'Cardiovascular disease diagnostic equipment industry.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse books on a wide variety of disciplines and organise your bibliography correctly.

1

Insight, LLC Medtech. U.S. markets for cardiovascular disease diagnostic products. Newport Beach, CA: Medtech Insight, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Rosen, Shara. Trends in the early diagnosis of cardiovascular disease: Worldwide market opportunities. New York: Kalorama Information, 2001.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Inc, Medical Data International. European markets for cardiovascular diagnostics, 2000-2005. Santa Ana, Calif. (5 Hutton Centre Dr., Suite 1100 Santa Ana, Calif. 92707): Medical Data International, 2000.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Inc, Medical Data International. U.S. markets for cardiovascular diagnostics, 2000-2005. Santa Ana, Calif: Medical Data International, 2000.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Inc, Medical Data International, ed. Targeted in vivo diagnostics & therapeutics: Oncology, infectious disease, autimmune & cardiovascular applications. Irvine, CA: Medical Data International, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Inc, Biomedical Business International, ed. Growth markets in diagnostic cardiology: April 16, 1992, Dallas, Texas : a one-day business conference. [Santa Ana, CA] (1524 Brookhollow Dr., Santa Ana 92705): BBI, 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Insight, LLC Medtech. U.S. markets for breast disease detection and diagnostic technologies. Newport Beach , CA: Medtech Insight, 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Inc, Biomedical Business International, ed. European markets for diagnostic and interventional cardiovascular catheters and supplies. Santa Ana, CA: Biomedical Business International, 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Corporation, InteLab, ed. U.S. markets for diagnostic and interventional cardiovascular catheters, 1993-2000. Mission Viejo, CA (26861 Trabuco Rd., E-64, Mission Viejo 92691): InteLab Corp., 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Frost & Sullivan., ed. U.S. markets for immune disease diagnostic products. New York, N.Y: Frost & Sullivan, 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
11

Insight, LLC Medtech. U.S. markets for breast disease detection and diagnostic technologies, 2001-2011. Tustin, CA: Medtech Insight, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
12

Corporation, Market Intelligence Research, ed. World cardiovascular diagnostic & therapeutic equipment markets: Multi-billion dollar battle : technology advances vs. cost constraints. Mountain View, CA: Market Intelligence, 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
13

Inc, Biomedical Business International, ed. AIDS diagnostic and therapeutic developments in non-U.S. markets. Santa Ana, CA, U.S.A: Biomedical Business International, 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
14

Medical, Data International Inc. U.S. markets for stroke management products. Irvine, Calif: MDI, Medical Data International, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
15

Insight, LLC Medtech. U.S. markets for stroke management products. Newport Beach, CA: Medtech Insight, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
16

LLC, Medtech Insight, ed. European markets for minimally invasive cardiac surgery and intracoronary diagnostic devices. Newport Beach, CA (23 Corporate Plaza, Suite 125, Newport Beach 92660): Medtech Insight, 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
17

D, Jindal G., and Bhabha Atomic Research Centre, eds. Electrical impedance and photo plethysmography for medical applications. Mumbai: Bhabha Atomic Research Centre, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
18

Consultants, Boston Medical, ed. Sexually transmitted diseases, 1984-1992: A confidential multi-client report. Boston (100 Fifth Ave. Waltham, MA., 02154): Boston Biomedical Consultants, 1985.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
19

Frost & Sullivan. AIDS diagnostic, monitoring, and therapeutic markets: Technological assessment and financial impact. Mountain View, CA: Frost & Sullivan, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
20

A, Mandlik Sadhana, and Bhabha Atomic Research Centre, eds. Anu-photo rheography for applications in clinical medicine. Mumbai: Bhabha Atomic Research Centre, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
21

IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, World Health Organization, and International Agency for Research on Cancer., eds. Man-made vitreous fibres. Lyon, France: International Agency for Research on Cancer, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
22

Cardiac diagnostic imaging markets. Mountain View, CA, USA: Market Intelligence Research Co., 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
23

Trends in the world cardiac diagnostic imaging systems markets: Procedural demands trigger high growth. Mountain View, CA: Market Intelligence Research Corp., 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
24

3D Computed Tomography Virtual Intravascular Endoscopy. Nova Science Publishers Inc, 2013.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
25

Diagnostic and interventional cardiovascular catheters and supplies markets. Santa Ana, CA (1524 Brookhollow Dr., Santa Ana 92705-5426): Biomedical Business International, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
26

Noninvasive cardiovascular and cardiorespiratory diagnostic devices (U.S. and international). Tustin, CA (17722 Irvine Blvd., Tustin 92680): Biomedical Business International, 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
27

U.S. sexually transmitted diseases diagnostic tests market. Mountain View, CA, USA (2525 Charleston Rd., Mountain View 94043): Market Intelligence Research Corp., 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
28

AIDS diagnostic and therapeutic developments in the U.S. market. Santa Ana, Calif. (1524 Brookhollow Dr., Santa Ana, 92705-5426): Biomedical Business International, 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
29

9th annual frontiers in cardiovascular medicine: November 17, 1992, New Orleans, Louisiana : a one-day business conference. [Santa Ana, CA] (1524 Brookhollow Dr., Santa Ana 92705): BBI, 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
30

The Implications of AIDS for the in vitro diagnostic products industry: Stouffer's National Conference Center, Crystal City, Virginia, November 13, 1985. Washington, D.C. (1030 15th St., N.W., Washington 20005): Health Industry Manufacturers Association, 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
31

Banerjee, Amitava, and Kaleab Asrress. Screening for cardiovascular disease. Edited by Patrick Davey and David Sprigings. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199568741.003.0351.

Full text
Abstract:
Screening involves testing asymptomatic individuals who have risk factors, or individuals who are in the early stages of a disease, in order to decide whether further investigation, clinical intervention, or treatment is warranted. Therefore, screening is classically a primary prevention strategy which aims to capture disease early in its course, but it can also involve secondary prevention in individuals with established disease. In the words of Geoffrey Rose, screening is a ‘population’ strategy. Examples of screening programmes are blood pressure monitoring in primary care to screen for hypertension, and ultrasound examination to screen for abdominal aortic aneurysm. The effectiveness and feasibility of screening are influenced by several factors. First, the diagnostic accuracy of the screening test in question is crucial. For example, exercise ECG testing, although widely used, is not recommended in investigation of chest pain in current National Institute for Health and Care Excellence guidelines, due to its low sensitivity and specificity in the detection of coronary artery disease. Moreover, exercise ECG testing has even lower diagnostic accuracy in asymptomatic patients with coronary artery disease. Second, physical and financial resources influence the decision to screen. For example, the cost and the effectiveness of CT coronary angiography and other new imaging modalities to assess coronary vasculature must be weighed against the cost of existing investigations (e.g. coronary angiography) and the need for new equipment and staff training and recruitment. Finally, the safety of the investigation is an important factor, and patient preferences and physician preferences should be taken into consideration. However, while non-invasive screening examinations are preferable from the point of view of patients and clinicians, sometimes invasive screening tests may be required at a later stage in order to give a definitive diagnosis (e.g. pressure wire studies to measure fractional flow reserve in a coronary artery). The WHO’s principles of screening, first formulated in 1968, are still very relevant today. Decision analysis has led to ‘pathways’ which guide investigation and treatment within screening programmes. There is increasing recognition that there are shared risk factors and shared preventive and treatment strategies for vascular disease, regardless of arterial territory. The concept of ‘vascular medicine’ has gained credence, leading to opportunistic screening in other vascular territories if an individual presents with disease in one territory. For example, post-myocardial infarction patients have higher incidence of cerebrovascular and peripheral arterial disease, so carotid duplex scanning and measurement of the ankle–brachial pressure index may be valid screening approaches for arterial disease in other territories.
APA, Harvard, Vancouver, ISO, and other styles
32

Products markets for sexually transmitted diseases testing. Fairfield, CT (119 Sherman Ct., Fairfield 06430): Delco Scientific Resources, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
33

European infectious and sexually transmitted disease diagnostic product markets: Emergence of significant new products entices new vendors. Mountain View, CA: Frost & Sullivan, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
34

Crandall, Mary Anne. Treatment and diagnosis of sexually transmitted diseases. Business Communications Co, 2001.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
35

Beyond second opinions: Making choices about fertility treatment. Berkeley: University of California Press, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography